e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Clinical aspects of continuous positive airway pressure therapy
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Insomnia, OSAS and CPAP treatment
X. L. Nguyen, D. Rakotonanahary, B. Fleury (Paris, France)
Source:
Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Session:
Clinical aspects of continuous positive airway pressure therapy
Session type:
Thematic Poster Session
Number:
766
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
X. L. Nguyen, D. Rakotonanahary, B. Fleury (Paris, France). Insomnia, OSAS and CPAP treatment. Eur Respir J 2008; 32: Suppl. 52, 766
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Tri-level ventilation versus CPAP treatment in treatment of complex sleep apnoea syndrome
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015
Residual sleepiness in patients with OSA on CPAP
Source: Eur Respir J 2009; 34: 1209
Year: 2009
Effects of CPAP treatment on anxiety and depression in patients with OSAS
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017
REM rebound during CPAP titration as a predictor of chronic CPAP compliance
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015
The impact of CPAP on circulating IGF-1 in patients with OSAS
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016
CPAP treatment response in obstructive sleep apnea using the AERScore predictor
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults II: questionnaires, epidemiology and sleep studies
Year: 2015
Patterns of CPAP usage in patients with minimally symptomatic OSA
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015
Insomnia related to sleep apnoea: effect of long-term auto-adjusting positive airway pressure treatment
Source: Eur Respir J 2013; 41: 593-600
Year: 2013
Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009
Humidification of CPAP for obstructive sleep apnoea
Source: Annual Congress 2005 - Upper airway interventions in OSA patients
Year: 2005
Compliance with nCPAP in elderly patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2004; 24: Suppl. 48, 569s
Year: 2004
Home automated CPAP titration is as effective as hospital CPAP titration in patients with obstructive sleep apnoea hypopnoea syndrome (OSAHS)
Source: Eur Respir J 2004; 24: Suppl. 48, 566s
Year: 2004
Outcome with CPAP in patients with suspected sleep apnea syndrome
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007
PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment
Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing
Year: 2012
The positive effect of CPAP therapy on the level of liver enzymes in obstructive sleep apnea patients
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015
CPAP treatment for obstructive sleep apnoea syndrome after CPAP training term
Source: Eur Respir J 2002; 20: Suppl. 38, 102s
Year: 2002
Hypertension among obstructive sleep apnea patients compared to controls. Two year change after starting treatment with CPAP
Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing
Year: 2013
Improved adherence to CPAP by telemetric support in newly diagnosed OSAS patients
Source: Annual Congress 2013 –Ask, see and do: old and new technology in sleep disordered breathing
Year: 2013
Obstructive sleep apnea syndrome and insomnia: The development of insomnia symptoms with CPAP treatment
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011
The effect of CPAP on blood pressure in patients with OSAS and resistant hypertension followed 1 year
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept